Alsberge Joseph B, Lee Daniel Y, Jumper J Michael
Department of Ophthalmology, Northwest Permanente, Portland, OR, USA.
West Coast Retina Medical Group, San Francisco, CA, USA.
Am J Ophthalmol Case Rep. 2022 Mar 9;26:101482. doi: 10.1016/j.ajoc.2022.101482. eCollection 2022 Jun.
To report a case of central serous chorioretinopathy (CSC) associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use.
A 34-year-old man presented for evaluation of a "cloud" in his vision for three months. He was taking Adderall for attention deficit hyperactivity disorder and mometasone 0.1% topical cream for eczema. He was found to have subretinal fluid in the left eye consistent with CSC. The subretinal fluid persisted despite cessation of the steroid cream but resolved after cessation of the Adderall. The subretinal fluid returned when the patient restarted Adderall and again resolved after he stopped it for a second time.
Though we cannot prove causality, the course of events was suggestive of a direct relationship between Adderall use and CSC in this patient, with exogenous steroid as a possible modifying factor.
报告一例与安非他明(右苯丙胺 - 苯丙胺)及局部使用类固醇相关的中心性浆液性脉络膜视网膜病变(CSC)病例。
一名34岁男性因视物有“云雾感”三个月前来就诊。他因注意力缺陷多动障碍服用安非他明,因湿疹使用0.1%的莫米松局部乳膏。检查发现其左眼存在与CSC相符的视网膜下液。尽管停用了类固醇乳膏,但视网膜下液仍持续存在,而停用安非他明后视网膜下液消退。当患者重新开始服用安非他明时,视网膜下液再次出现,在他再次停药后又消退。
尽管我们无法证明因果关系,但一系列事件提示在该患者中,安非他明的使用与CSC之间存在直接关系,外源性类固醇可能是一个影响因素。